Form 4: Guardant Health Co-CEO AmirAli Talasaz Reports Stock Transactions

AmirAli Talasaz, Co-CEO of Guardant Health, reports the acquisition and disposal of common stock related to restricted stock unit vesting.

Summary

• On June 30, 2024, AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, Inc., reported transactions involving the company's common stock.
• These transactions included the acquisition of 11,462 shares through the vesting of restricted stock units and the disposal of 5,809 shares to cover tax withholding obligations.
• Following these transactions, Talasaz directly owns 2,198,780 shares of Guardant Health common stock and 22,923 restricted stock units.

Sentiment

Score: 5

Explanation: The Form 4 filing itself is a neutral event. It simply reports transactions by an insider. The vesting of RSUs is generally a positive sign, but the sale to cover taxes is a standard procedure.

Positives

• The vesting of restricted stock units indicates a continued alignment of the executive's interests with those of the company and its shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their holdings in the company's stock.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to routine executive compensation and tax obligations.

Key Dates